Author | Jane Turner, PhD


Fear of Cancer Recurrence: A Practical Guide for Clinicians

January 15, 2018

ByPhyllis Butow, MClinPsych, MPH, PhD|Louise Sharpe, PhD|Belinda Thewes, PhD|Jane Turner, PhD|Jemma Gilchrist, MClinPsych|Jane Beith, MBBS, PhD

With increasing cancer survival, fear of cancer recurrence (FCR) is becoming a prominent clinical issue. FCR is prevalent, distressing, and long-lasting, and can negatively impact patients’ quality of life, use of health services, and adherence to follow-up recommendations. Novel targeted therapies may increase risk of FCR because of longer treatment duration and follow-up, increased prognostic precision, and omission of treatment based on genomic status.